New Potomac Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$4.08M Sell
20,685
-1,205
-6% -$238K 2.1% 13
2024
Q2
$3.75M Buy
21,890
+345
+2% +$59.2K 2.05% 14
2024
Q1
$3.92M Buy
21,545
+206
+1% +$37.5K 2.18% 10
2023
Q4
$3.31M Buy
21,339
+160
+0.8% +$24.8K 1.97% 16
2023
Q3
$3.16M Buy
21,179
+40
+0.2% +$5.96K 2.17% 13
2023
Q2
$2.85M Sell
21,139
-55
-0.3% -$7.41K 1.88% 17
2023
Q1
$3.38M Sell
21,194
-150
-0.7% -$23.9K 2.34% 9
2022
Q4
$3.45M Buy
21,344
+24
+0.1% +$3.88K 2.55% 6
2022
Q3
$2.86M Sell
21,320
-2,240
-10% -$301K 2.42% 10
2022
Q2
$3.61M Sell
23,560
-65
-0.3% -$9.95K 2.9% 6
2022
Q1
$3.83M Sell
23,625
-275
-1% -$44.6K 2.69% 8
2021
Q4
$3.24M Buy
23,900
+35
+0.1% +$4.74K 2.1% 18
2021
Q3
$2.57M Buy
23,865
+265
+1% +$28.6K 1.78% 26
2021
Q2
$2.66M Buy
23,600
+80
+0.3% +$9.01K 1.81% 23
2021
Q1
$2.55M Sell
23,520
-215
-0.9% -$23.3K 1.87% 23
2020
Q4
$2.54M Sell
23,735
-1,000
-4% -$107K 1.84% 22
2020
Q3
$2.17M Buy
24,735
+90
+0.4% +$7.89K 1.73% 25
2020
Q2
$2.42M Sell
24,645
-740
-3% -$72.7K 2.16% 17
2020
Q1
$1.93M Sell
25,385
-695
-3% -$53K 2.11% 18
2019
Q4
$2.31M Buy
26,080
+12,200
+88% +$1.08M 2.15% 15
2019
Q3
$1.05M Buy
13,880
+200
+1% +$15.1K 1.05% 41
2019
Q2
$995K Sell
13,680
-620
-4% -$45.1K 1.01% 43
2019
Q1
$1.15M Sell
14,300
-1,105
-7% -$89K 1.17% 40
2018
Q4
$1.42M Buy
15,405
+90
+0.6% +$8.3K 1.53% 34
2018
Q3
$1.45M Sell
15,315
-7,900
-34% -$747K 1.34% 39
2018
Q2
$2.15M Sell
23,215
-345
-1% -$32K 2.08% 18
2018
Q1
$2.23M Sell
23,560
-1,040
-4% -$98.4K 2.19% 13
2017
Q4
$2.38M Buy
+24,600
New +$2.38M 2.27% 11